Cargando…
The lungs need to be deflated: effects of glycopyrronium on lung hyperinflation in COPD patients
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation caused by bronchial alterations, small airways disease and parenchymal destruction. In patients with COPD the structural and functional lung alterations can progress more or less rapidly from the initial s...
Autor principal: | Sanguinetti, Claudio M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229742/ https://www.ncbi.nlm.nih.gov/pubmed/24690294 http://dx.doi.org/10.1186/2049-6958-9-19 |
Ejemplares similares
-
Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial
por: Santus, Pierachille, et al.
Publicado: (2015) -
No room to breathe: the importance of lung hyperinflation in COPD
por: Thomas, Mike, et al.
Publicado: (2013) -
Longitudinal changes in lung hyperinflation in COPD
por: Park, Jimyung, et al.
Publicado: (2017) -
Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD
por: Siler, Thomas M., et al.
Publicado: (2021) -
Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study)
por: Watz, Henrik, et al.
Publicado: (2016)